MD Anderson Cancer — Houston, Texas

MD Anderson Cancer is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Melanoma, Blinatumomab, Revumenib.

Sponsors: Novartis Pharmaceuticals, M.D. Anderson Cancer Center, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer?

MD Anderson Cancer has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer conducted?

MD Anderson Cancer has 3 clinical trials on record, with 1 currently active. Their work covers Melanoma, Blinatumomab, Revumenib.

Is MD Anderson Cancer accredited by Crixeo Health?

MD Anderson Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.